Blue Engine Biologics, LLC
Records under this name other than the patents Blue Engine Biologics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 10 of 10 · Back to Blue Engine Biologics, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,741,282 | Method for treatment of tendinosis with platelet rich plasma Lapsed on the fee record Ended Jun 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2026 | From the USPTO record |
| US 7,462,268 | Particle/cell separation device and compositions Term ended Term ended Mar 29, 2026 · From the USPTO record | Term ended | Term ended Mar 29, 2026 | From the USPTO record |
| US 7,678,780 | Method of treating cancer using platelet releasate Term ended Term ended Jan 13, 2026 · From the USPTO record | Term ended | Term ended Jan 13, 2026 | From the USPTO record |
| US 8,088,371 | Compositions and minimally invasive methods for treating peripheral vascular disease Term ended Term ended Aug 27, 2025 · From the USPTO record | Term ended | Term ended Aug 27, 2025 | From the USPTO record |
| US 8,142,993 | Method of preparing neutrophil-depleted platelet-rich plasma Term ended Term ended Aug 16, 2025 · From the USPTO record | Term ended | Term ended Aug 16, 2025 | From the USPTO record |
| US 7,608,258 | Method for Treatment of Tendinosis Using Platelet Rich Plasma Formerly held Term ended Ended no later than Jun 14, 2024 · Low confidence | Term ended | Ended no later than Jun 14, 2024 | Low confidence |
| US 9,320,762 | Compositions and minimally invasive methods for treating incomplete tissue repair Lapsed on the fee record Ended Apr 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2024 | From the USPTO record |
| US 7,314,617 | PRP composition and minimally invasive method for treating myocardial infarction Term ended Term ended Dec 20, 2023 · From the USPTO record | Term ended | Term ended Dec 20, 2023 | From the USPTO record |
| US 6,811,777 | Compositions and minimally invasive methods for treating incomplete connective tissue repair Term ended Term ended Apr 11, 2023 · From the USPTO record | Term ended | Term ended Apr 11, 2023 | From the USPTO record |
| US 8,617,539 | Method of administration of platelet-rich plasma to treat an acute cardiac dysfunction Term ended Ended no later than Apr 11, 2023 · From the USPTO record | Term ended | Ended no later than Apr 11, 2023 | From the USPTO record |